A 12-week clinical trial of talsaclidine, a muscarinic agonist, in the treatment of mild to moderate Alzheimer's disease

被引：0
|
作者：
Jones, R
Raschig, A
Müller, A
Müller, S
Ingelheim, B
机构：
[1] Res Inst Care Elderly, Bath, Somerset, England
[2] Boehringer Ingelheim Pharma KG, Biberach, Germany
来源：
NEUROBIOLOGY OF AGING | 2002年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
462
引用
收藏
页码：S122 / S122
页数：1
相关论文
共 50 条
  • [41] A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease
    Akhondzadeh, Shahin
    Sabet, Mehdi Shafiee
    Harirchian, Mohammad Hossein
    Togha, Mansoreh
    Cheraghmakani, Hamed
    Razeghi, Soodeh
    Hejazi, Seyyed Shamssedin
    Yousefi, Mohammad Hossein
    Alimardani, Roozbeh
    Jamshidi, Amirhossein
    Rezazadeh, Shams-Ali
    Yousefi, Aboulghasem
    Zare, Farhad
    Moradi, Atbin
    Vossoughi, Ardalan
    PSYCHOPHARMACOLOGY, 2010, 207 (04) : 637 - 643
  • [42] A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer’s disease
    Shahin Akhondzadeh
    Mehdi Shafiee Sabet
    Mohammad Hossein Harirchian
    Mansoreh Togha
    Hamed Cheraghmakani
    Soodeh Razeghi
    Seyyed Shamssedin Hejazi
    Mohammad Hossein Yousefi
    Roozbeh Alimardani
    Amirhossein Jamshidi
    Shams-Ali Rezazadeh
    Aboulghasem Yousefi
    Farhad Zare
    Atbin Moradi
    Ardalan Vossoughi
    Psychopharmacology, 2010, 207 : 637 - 643
  • [43] Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: Data from a multicenter, randomized, double-blind, 12-week trial
    Elliott, WJ
    Calhoun, DA
    DeLucca, PT
    Gazdick, LP
    Kerns, DE
    Zeldin, RK
    CLINICAL THERAPEUTICS, 2001, 23 (08) : 1166 - 1179
  • [44] No effects of a 12-week supervised exercise therapy program on gait in patients with mild to moderate osteoarthritis: a secondary analysis of a randomized trial
    Eitzen, Ingrid
    Fernandes, Linda
    Nordsletten, Lars
    Risberg, May Arna
    JOURNAL OF NEGATIVE RESULTS IN BIOMEDICINE, 2015, 14
  • [45] Is a 12-week trial sufficient to evaluate clinical responses to etanercept or MTX treatment in early RA?
    Kavanaugh, Arthur
    Keystone, Edward
    Feng, JingYuan
    Hooper, Michele
    RHEUMATOLOGY, 2010, 49 (06) : 1201 - 1203
  • [46] Efficacy and tolerability of galantamine in the treatment of patients with mild to moderate Alzheimer's disease in the routine clinical practice
    Kogoj, A.
    Denislic, M.
    Ambrozic, D.
    Hren, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 190 - 190
  • [47] Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer’s disease
    Yuqi Qiu
    Diane M. Jacobs
    Karen Messer
    David P. Salmon
    Cheryl L. Wellington
    Sophie Stukas
    Carolyn Revta
    James B. Brewer
    Gabriel C. Léger
    Brianna Askew
    Lia Donahue
    Stephen Kaplita
    Vladimir Coric
    Irfan A. Qureshi
    Howard H. Feldman
    Alzheimer's Research & Therapy, 17 (1)
  • [48] Mindfulness Prevents Depression and Psychopathology in Elderly People with Mild to Moderate Alzheimer's Disease: A Randomized Clinical Trial
    Quintana-Hernandez, Domingo J.
    Rojas-Hernandez, Jaime
    Santana-Del Pino, Angelo
    Cespedes Suarez, Carmen
    Pellejero Silva, Monica
    Teresa Miro-Barrachina, Maria
    Ibanez Fernandez, Ignacio
    Estupinan Lopez, Jose Antonio
    Borkel, Lucas F.
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 91 (01) : 471 - 481
  • [49] Rivastigmine in current clinical practice in patients with mild to moderate Alzheimer's disease
    Dartigues, JF
    Goulley, F
    Bourdeix, I
    Péré, JJ
    Barberger-Gateau, P
    REVUE NEUROLOGIQUE, 2002, 158 (8-9) : 807 - 812
  • [50] Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease - A randomized controlled trial
    Mulnard, RI
    Cotman, CW
    Kawas, C
    van Dyck, CH
    Sano, H
    Doody, R
    Koss, E
    Pfeiffer, E
    Jin, S
    Gamst, A
    Grundman, M
    Thomas, R
    Thal, LJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (08): : 1007 - 1015
12345